Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options
Sanatate
In This Story HIMS -1.80% LLY +1.07% NVO +0.19% BAC +0.47% Hims & Hers ( HIMS -1.80% ) stock slid Wednesday, a day after the company announced new weight-loss drug offerings — an update that left investors unimpressed. Suggested Reading Trump's 'reciprocal' tariffs will hurt most countries doing business with the U.S. Blaming China for price hikes could backfire for companies, PR exec says 42% of Americans support tariffs despite rising prices, exec says DraftKings CEO on March Madness, AI, and
din zilele anterioare